These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 3164079)

  • 1. [Susceptibility of clinical isolates against cefotiam, cefmenoxime, and cefsulodin: comparative study between MS-2 clinical system and disc agar method].
    Honda I; Ishimori A; Kano T; Sato N
    Rinsho Byori; 1988 Feb; 36(2):196-202. PubMed ID: 3164079
    [No Abstract]   [Full Text] [Related]  

  • 2. [In vitro antibacterial activity of cefmenoxime (SCE 1365)].
    Brun Y; Forey F; Coulet M; Fleurette J; Bryskier A
    Pathol Biol (Paris); 1983 May; 31(5):343-6. PubMed ID: 6312394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Laboratory evaluation of cefmenoxime: a new cephalosporin. In vitro and in vivo antibacterial activities and pharmacokinetic properties.
    Matsumoto K; Nagatake T; Uzuka Y; Harada T; Rikitomi N
    Chemotherapy; 1983; 29(2):80-8. PubMed ID: 6301776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Bacteriological in vitro studies with a new cephalosporin: cefotiam (author's transl)].
    Grimm H
    Arzneimittelforschung; 1981; 31(11):1867-9. PubMed ID: 6274364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Sensitivity to cefotiam of 494 hospital bacterial strains. Determination of minimal inhibitory concentration and comparison with other beta-lactams].
    Reynaud A; Desnoes M; Derriennic M; Courtieu AL
    Pathol Biol (Paris); 1985 May; 33(5):313-9. PubMed ID: 3929216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical bacteriological studies on cefotiam and cefsulodin in the field of otorhinolaryngology].
    Deguchi K; Fukayama S; Nishimura Y
    Jpn J Antibiot; 1982 May; 35(5):1187-98. PubMed ID: 6290705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [In vitro bacteriostatic activity of cefmenoxime (SCE 1365), cefotaxime and moxalactam].
    Husson MO; Bryskier A; Izard D; Leclerc H
    Pathol Biol (Paris); 1983 May; 31(5):347-50. PubMed ID: 6312395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [In vitro activity of cefmenoxime (SCE 1365) against 616 hospital strains of gram-negative bacilli chosen for beta-lactam resistance. Comparison with cefotaxime, lamoxactam and ceftazidime].
    Le Noc P; Bryskier A; Le Noc D
    Pathol Biol (Paris); 1983 May; 31(5):351-6. PubMed ID: 6312396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High performance liquid chromatographic assay of cefsulodin, cefotiam and cefmenoxime in serum and urine.
    Itakura K; Mitani M; Aoki I; Usui Y
    Chem Pharm Bull (Tokyo); 1982 Feb; 30(2):622-7. PubMed ID: 6284390
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical laboratory approach for determination of effective dose of cefotiam. Observation from disc susceptibility test and MICs].
    Uete T; Tsuzaki Y; Furukawa S; Matsuo K
    Jpn J Antibiot; 1982 Jun; 35(6):1441-61. PubMed ID: 6290707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the renal excretory mechanisms of cefmenoxime and other cephalosporins: effect of para-aminohippurate on renal clearance and intrarenal distribution of cephalosporins in rabbits.
    Yamazaki I; Shirakawa Y; Fugono T
    J Antibiot (Tokyo); 1981 Nov; 34(11):1476-85. PubMed ID: 6274834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A study on the disc sensitivity test for cefmenoxime].
    Kanazawa Y; Kuramata T; Matsumoto K
    Jpn J Antibiot; 1984 Jan; 37(1):176-83. PubMed ID: 6328060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Nonparametric approach to the determination of critical diameters. Comparison with conventional methods].
    Flandrois JP; Carret G
    Pathol Biol (Paris); 1984 Jun; 32(5 Pt 2):488-91. PubMed ID: 6087246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative in vitro activities of cefmenoxime (SCE-1365) and newer cephalosporin derivatives of clinical utility.
    Ahonkhai VI; Cherubin CE; Shulman MA; Bancroft U
    Antimicrob Agents Chemother; 1982 Jun; 21(6):999-1002. PubMed ID: 6287933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of susceptibilities of anaerobic bacteria to cefmenoxime, ceftriaxone, and other antimicrobial compounds.
    Pollock HM; Holt J; Murray C
    Antimicrob Agents Chemother; 1983 May; 23(5):780-3. PubMed ID: 6307137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cefotiam, a new cephalosporin. Microbiological research, preliminary evaluation of its effect on phagocytosis and clinical multicenter research].
    Di Nola F; Arione R; Fabiano A; Ferrea G; Leone G; Loy A; Negro F; Pavesio D; Salassa B; Soranzo ML
    Minerva Med; 1986 Nov; 77(45-46):2163-82. PubMed ID: 3540731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparative evaluation of the antibacterial activity of cefotaxime and cephalotin by using an automated antimicrobial susceptibility determination system].
    Concia E; Marone P; Dos Santos C; Bono L
    Quad Sclavo Diagn; 1982 Jun; 18(2):223-32. PubMed ID: 6300953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [In vitro study of the synergistic effect of cefmenoxime-aminoglycoside combinations apropos of 148 strains of Enterobacteriaceae].
    Husson MO; Izard D; Bryskier A; Leclerc H
    Pathol Biol (Paris); 1984 May; 32(5):396-8. PubMed ID: 6330651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro activity of cefotaxime, ceftizoxime, cefmenoxime, and latamoxef in comparison with other beta-lactam antibiotics against recent clinical isolates of Haemophilus influenzae and Haemophilus parainfluenzae.
    Kawakami Y; Okimura Y; Horiuchi N; Kanai M
    Microbiol Immunol; 1982; 26(7):617-21. PubMed ID: 6290854
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparative efficacy of cefotiam, cefmenoxime, and ceftriaxone in experimental endocarditis and correlation with pharmacokinetics and in vitro efficacy.
    Pangon B; Joly V; Vallois JM; Abel L; Buré A; Brion N; Contrepois A; Carbon C
    Antimicrob Agents Chemother; 1987 Apr; 31(4):518-22. PubMed ID: 3300530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.